Cargando…
Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients
Autores principales: | Saverno, Kim R., Rochau, Ursula, Stenehjem, David D., Morley, Kimberly, Siebert, Uwe, Brixner, Diana I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437761/ https://www.ncbi.nlm.nih.gov/pubmed/22839687 http://dx.doi.org/10.18553/jmcp.2012.18.6.457 |
Ejemplares similares
-
Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis
por: Rochau, Ursula, et al.
Publicado: (2015) -
Payer perceptions on the use of economic models in oncology decision making
por: Biskupiak, Joseph, et al.
Publicado: (2021) -
Payer perceptions of the use of real-world evidence in oncology-based decision making
por: Brixner, Diana, et al.
Publicado: (2021) -
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online
por: Jahn, Beate, et al.
Publicado: (2017) -
Standardizing Quality Assessment of Observational Studies for Decision Making in Health Care
por: Brixner, Diana
Publicado: (2009)